EXOZ
Price
$6.38
Change
-$0.59 (-8.46%)
Updated
Jul 13 closing price
Capitalization
59.12M
Intraday BUY SELL Signals
MENS
Price
$2.21
Change
-$0.00 (-0.00%)
Updated
Jul 13 closing price
Capitalization
162.57M
Intraday BUY SELL Signals
Interact to see
Advertisement

EXOZ vs MENS

EXOZ vs MENS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EXOZ vs. MENS commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXOZ is a Buy and MENS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (EXOZ: $6.38 vs. MENS: $2.21)
Brand notoriety: EXOZ and MENS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXOZ: 54% vs. MENS: 51%
Market capitalization -- EXOZ: $59.12M vs. MENS: $162.57M
EXOZ [@Biotechnology] is valued at $59.12M. MENS’s [@Biotechnology] market capitalization is $162.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXOZ’s FA Score shows that 0 FA rating(s) are green whileMENS’s FA Score has 1 green FA rating(s).

  • EXOZ’s FA Score: 0 green, 5 red.
  • MENS’s FA Score: 1 green, 4 red.
According to our system of comparison, MENS is a better buy in the long-term than EXOZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXOZ’s TA Score shows that 4 TA indicator(s) are bullish while MENS’s TA Score has 5 bullish TA indicator(s).

  • EXOZ’s TA Score: 4 bullish, 4 bearish.
  • MENS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MENS is a better buy in the short-term than EXOZ.

Price Growth

EXOZ (@Biotechnology) experienced а -22.10% price change this week, while MENS (@Biotechnology) price change was +0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MENS($163M) has a higher market cap than EXOZ($59.1M). EXOZ YTD gains are higher at: -41.468 vs. MENS (-44.051).
EXOZMENSEXOZ / MENS
Capitalization59.1M163M36%
EBITDA-9.86MN/A-
Gain YTD-41.468-44.05194%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash1.45MN/A-
Total Debt1.17MN/A-
TECHNICAL ANALYSIS
Technical Analysis
EXOZMENS
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
90%
Bullish Trend 5 days ago
90%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EXOZ
Daily Signal:
Gain/Loss:
MENS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRSRX112.10N/A
N/A
Hood River Small-Cap Growth Investor
BMDIX20.59N/A
N/A
Baird Mid Cap Growth Institutional
RYCMX57.30N/A
N/A
Rydex Russell 2000 1.5x Strategy C
GTSIX38.45N/A
N/A
Invesco Small Cap Growth Inv
CGEOX20.70-0.38
-1.80%
Calamos Global Equity R6

EXOZ and

Correlation & Price change

A.I.dvisor tells us that EXOZ and CTNM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXOZ and CTNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXOZ
1D Price
Change %
EXOZ100%
-8.46%
CTNM - EXOZ
24%
Poorly correlated
-3.75%
ORIC - EXOZ
21%
Poorly correlated
-3.59%
MENS - EXOZ
11%
Poorly correlated
N/A
ASBP - EXOZ
6%
Poorly correlated
N/A
ALNY - EXOZ
6%
Poorly correlated
-3.58%
More

MENS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MENS has been loosely correlated with VTGN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if MENS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MENS
1D Price
Change %
MENS100%
N/A
VTGN - MENS
57%
Loosely correlated
-2.05%
KYTX - MENS
34%
Loosely correlated
-8.43%
BNTC - MENS
29%
Poorly correlated
-3.20%
TRAW - MENS
25%
Poorly correlated
-9.88%
ASND - MENS
22%
Poorly correlated
-1.93%
More